Medication Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medication stocks.

Medication Stocks Recent News

Date Stock Title
Nov 21 NVS Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
Nov 21 NVS Novartis buys gene therapy developer Kate for up to $1.1B
Nov 21 NVS Novartis raises mid-term sales guidance
Nov 21 NVS Novartis Lifts Midterm Sales Guidance Amid U.S. Expansion
Nov 21 NVS Novartis wagers more than $1B on gene therapies for the nervous system
Nov 21 NVS Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Nov 20 CALC CalciMedica Announces Presentations at Upcoming Medical Meetings
Nov 19 LQDA 3 US Growth Stocks With At Least 10% Insider Ownership
Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Nov 18 ARTL Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit
Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
Nov 15 NVS FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
Nov 15 LQDA Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off
Nov 15 NVS Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
Nov 15 NVS Ouch: Why a Healthcare Selloff Really Hurts in Europe
Nov 15 LQDA Liquidia Third Quarter 2024 Earnings: Beats Expectations
Medication

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Drugs are classified in various ways. One of the key divisions is by level of control, which distinguishes prescription drugs (those that a pharmacist dispenses only on the order of a physician, physician assistant, or qualified nurse) from over-the-counter drugs (those that consumers can order for themselves). Another key distinction is between traditional small-molecule drugs, usually derived from chemical synthesis, and biopharmaceuticals, which include recombinant proteins, vaccines, blood products used therapeutically (such as IVIG), gene therapy, monoclonal antibodies and cell therapy (for instance, stem-cell therapies). Other ways to classify medicines are by mode of action, route of administration, biological system affected, or therapeutic effects. An elaborate and widely used classification system is the Anatomical Therapeutic Chemical Classification System (ATC system). The World Health Organization keeps a list of essential medicines.
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions, drug pricing. Controversies have arisen over drug pricing and disposal of used drugs.

Browse All Tags